Sanofi, Novo, Lilly Look To Ditch Minn. AG's Insulin Suit
Sanofi-Aventis U.S. LLC, Novo Nordisk Inc. and Eli Lilly and Co. urged a New Jersey federal judge Monday to toss the Minnesota attorney general's insulin pricing lawsuit against them, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article